Precision Patient Outcomes
The FTC filed a complaint in November 2022 against California-based Precision Patient Outcomes, Inc. and its CEO Margrett Priest Lewis for marketing an OTC dietary supplement — containing only vitamins, zinc, and a flavonoid — as an effective treatment to mitigate the effects of COVID-19. The FTC alleged the defendants engaged in deceptive practices by making unsupported disease-treatment claims for a product with no demonstrated efficacy against COVID-19. In February 2024, a settlement order was announced barring the defendants from the alleged deceptive practices.
Flagged claims (1)
effective treatment to mitigate the effects of COVID-19
Required actions (2)
the FTC filed a complaint in court seeking civil penalties against California-based Precision Patient Outcomes, Inc. and the company's CEO Margrett Priest Lewis
the FTC announced an order settling its allegations that bars the defendants from the alleged deceptive practices
Does your site contain similar claims?
The free site audit scans your whole site against every entry in this Atlas. Most nutrition / supplements sites match 3-6 patterns.
Run my free site auditWorried about one specific page, ad, or email? Paste it into the free Claim Checker and see what the FDA and FTC would flag, with the precedent next to each one. No email required.
Check specific copy in the Claim Checker